Novartis Ag (NVS) Non-Current Assets (2009 - 2025)

Novartis Ag (NVS) has 12 years of Non-Current Assets data on file, last reported at $80.5 billion in Q4 2025.

• Quarterly Non-Current Assets rose 10.96% year-over-year to $80.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $80.5 billion (up 10.96% YoY) and the FY2025 annual result came in at $80.5 billion, up 10.96% from the prior year.
• Non-Current Assets advanced to $80.5 billion in Q4 2025 per NVS's latest filing, from $78.5 billion in the prior quarter.
• The five-year high for Non-Current Assets was $86.1 billion in Q4 2021, with the low at $57.5 billion in Q2 2021.
• Average Non-Current Assets over 5 years is $75.9 billion, with a median of $78.0 billion recorded in 2023.
• Year-over-year, Non-Current Assets surged 47.42% in 2022 and declined 13.76% in 2023.
• Novartis Ag's Non-Current Assets stood at $86.1 billion in 2021, then declined by 6.43% to $80.5 billion in 2022, then decreased by 13.76% to $69.5 billion in 2023, then rose by 4.43% to $72.5 billion in 2024, then grew by 10.96% to $80.5 billion in 2025.
• Business Quant data shows NVS's Non-Current Assets at $80.5 billion in Q4 2025, $78.5 billion in Q2 2025, and $72.5 billion in Q4 2024.